Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/224901
Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background X-linked adrenoleukodystrophy (X-ALD) is highly variable, ranging from slowly progressive adreno-myeloneuropathy to severe brain demyelination and inflammation (cerebral ALD, CALD) affecting males with childhood peak onset. Risk models integrating blood-based biomarkers to indicate CALD onset, enabling timely interventions, are lacking. Therefore, we evaluated the prognostic value of blood biomarkers in addition to current neuroimaging predictors for early detection of CALD.Methods We measured blood biomarkers in a retrospective, male CALD risk-assessment cohort consisting of 134 X-ALD patients and 66 controls and in a phenotype-blinded validation set (25 X-ALD boys, 4-13 years) using Simoa (R) and Luminex (R) technologies.Findings Among 25 biomarkers indicating axonal damage, astrocye/microglia activation, or immune-cell recruitment, neurofilament light chain (NfL) had the highest prognostic value for early indication of childhood/adolescent CALD. A plasma NfL cut-off level of 8.33 pg/mL, determined in the assessment cohort, correctly discriminated CALD with an accuracy of 96% [95% CI: 80-100] in the validation group. Multivariable logistic regression models revealed that combining NfL with GFAP or cytokines/chemokines (IL-15, IL-12p40, CXCL8, CCL11, CCL22, and IL-4) that were significantly elevated in CALD vs healthy controls had no additional benefit for detecting neuroinflammation. Some cytokines/chemokines were elevated only in childhood/adolescent CALD and already upregulated in eBioMedicineasymptomatic X-ALD children (IL-15, IL-12p40, and CCL7). In adults, NfL levels distinguished CALD but were lower than in childhood/adolescent CALD patients with similar (MRI) lesion severity. Blood GFAP did not differentiate CALD from non-inflammatory X-ALD.Interpretation Biomarker-based risk prediction with a plasma NfL cut-off value of 8.33 pg/mL, determined by ROC analysis, indicates CALD onset with high sensitivity and specificity in childhood X-ALD patients. A specific pro -inflammatory cytokine/chemokine profile in asymptomatic X-ALD boys may indicate a primed, immanent inflammatory state aligning with peak onset of CALD. Age-related differences in biomarker levels in adult vs childhood CALD patients warrants caution in predicting onset and progression of CALD in adults. Further evaluations are needed to assess clinical utility of the NfL cut-off for risk prognosis of CALD onset.
Matèries (anglès)
Citació
Citació
WEINHOFER, Isabelle, ROMMER, Paulus, GLEISS, Andreas, PONLEITNER, Markus, ZIERFUSS, Bettina, WAIDHOFER SÖLLNER, Petra, FOURCADE, Stéphane, GRABMEIER PFISTERSHAMMER, Katharina, REINERT, Marie christine, GÖPFERT, Jens, HEINE, Anne, YSKA, Hemmo a. f., CASASNOVAS, Carlos, CANTARÍN, Verónica, BERGNER, Caroline g., MALLACK, Eric, FORSS PETTER, Sonja, AUBOURG, Patrick, BLEY, Annette, ENGELEN, Marc, EICHLER, Florian, LUND, Troy c., PUJOL, Aurora, KÖHLER, Wolfgang, KÜHL, Jörn sven, BERGER, Johannes. Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy. _EBioMedicine_. 2023. Vol. 96, núm. 104781. [consulta: 24 de desembre de 2025]. ISSN: 2352-3964. [Disponible a: https://hdl.handle.net/2445/224901]